Related Experiment Video
Updated: Aug 23, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-kappaB-responsive gene
Keun-Wook Lee1, Doo-Sik Kim, Hyung-Joo Kwon
1Department of Biochemistry, College of Science, Yonsei University, Seoul 120-749, South Korea.
Abstract:
Oligodeoxynucleotides containing CpG motifs (CpG-ODNs) have gained attention because of their stimulatory effects on innate immune responses. CpG-ODN 1826 containing two GACGTT motifs is well known to activate the mouse immune cells while CpG-ODN 2006 containing three GTCGTT motifs is optimal for human cells. We have shown that stimulation of the human B cell line RPMI 8226 with CpG-ODN 1826 or 2006 results in the activation of IL-8 promoter and nuclear localization of NF-kappaB in the CG sequence- and phosphorothioate backbone modification-dependent manner. It was also demonstrated that myeloid differentiation protein and tumor necrosis factor receptor-associated factor 6 are involved in the signal transduction pathway triggered by the CpG-ODNs. Furthermore, phosphorothioate-modified CpG-ODN 1826 led to induce the NF-kappaB-responsive inflammatory cytokine gene expression in the cells. Experimental results indicated that the phosphorothioate derivative of CpG-ODN 1826 not only activates the mouse immune cells, but also stimulates NF-kappaB responsive gene expression in the human B cell line.
Insights
CpG-ODNs activate immune cells. Phosphorothioate-modified CpG-ODN 1826 stimulates human B cells, activating NF-kappaB and inflammatory gene expression, similar to its effect on mouse cells.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Oligodeoxynucleotides with CpG motifs (CpG-ODNs) are known to stimulate innate immune responses.
- CpG-ODN 1826 is effective in mouse cells, while CpG-ODN 2006 is optimal for human cells.
Purpose of the Study:
- To investigate the activation of IL-8 promoter and NF-kappaB in human B cells by CpG-ODN 1826 and 2006.
- To determine the role of CG sequence and phosphorothioate backbone modification in CpG-ODN activity.
- To identify signaling molecules involved in CpG-ODN triggered pathways.
Main Methods:
- Stimulation of human B cell line RPMI 8226 with CpG-ODN 1826 and 2006.
- Analysis of IL-8 promoter activation and NF-kappaB nuclear localization.
- Investigating the involvement of myeloid differentiation protein and tumor necrosis factor receptor-associated factor 6.
Main Results:
- CpG-ODN 1826 and 2006 activated the IL-8 promoter and NF-kappaB in human B cells in a sequence- and backbone-dependent manner.
- Myeloid differentiation protein and TRAF6 were implicated in the CpG-ODN signaling pathway.
- Phosphorothioate-modified CpG-ODN 1826 induced NF-kappaB-responsive inflammatory cytokine gene expression in human B cells.
Conclusions:
- Phosphorothioate-modified CpG-ODN 1826 activates human B cells, inducing NF-kappaB-responsive gene expression.
- CpG-ODN 1826 demonstrates cross-species activity, stimulating both mouse and human immune cells.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
09:51Generation of Stable Human Cell Lines with Tetracycline-inducible (Tet-on) shRNA or cDNA Expression
Published on: March 5, 2013
Related Concept Videos
Cell Specific Gene Expression
RNA Polymerase II Accessory Proteins
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Co-activators and Co-repressors
Negative Regulator Molecules
TGF - β Signaling Pathway